Login
$CYRX
$19.80 -$0.09 (0.45%) Live

Company Executives

Management Team

From the 10-K annual report
Officer Age In this role 2025 pay Source
Jerrell W. Shelton Also a director
President, CEO
Title from the Form 4 dated Aug 11, 2026
80 Not stated $2,375,524
Robert S. Stefanovich
Chief Financial Officer
Title from the Form 4 dated Jun 4, 2026
61 Not stated $1,119,615
Mark Sawicki
Senior Vice President and Chief Scientific Officer
53 Not stated $986,061
Edward J. Zecchini
Chief Digital and Technology Officer (CDTO)
65 Since 2024
2 years
$1,088,029

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
5 of 5
stated in the proxy; 1 not stated
Average tenure
9.2 years
from year joined
CEO also chairs the board
Yes
Jerrell W. Shelton
Director Age On board Independent Committees Other public boards 2025 pay Source
Jerrell W. Shelton
80 2012
14 years
Not stated None stated None stated Paid as CEO
Linda Baddour
67 2021
5 years
Independent
Audit Committee · Chair
Waters Corporation $421,793
Daniel M. Hancock
75 2019
7 years
Independent
Audit Committee Compensation Committee Scientific and Technology Committee
None stated $395,071
Robert Hariri, M.D., Ph.D.
66 2015
11 years
Independent
Scientific and Technology Committee · Chair
Celularity, Inc. $419,071
Ram M. Jagannath
49 2020
6 years
Independent None stated None stated $70,000
Ramkumar Mandalam, Ph.D.
61 2014
12 years
Independent
Compensation Committee · Chair
None stated $430,974

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 22, 2026
Blackstone Freeze Parent
Amount not stated

Registration rights agreement entered into in connection with the Private Placement, granting customary registration rights for Series C Preferred Stock, underlying common stock and common stock issued in the Private Placement.

With Blackstone Freeze Parent Open in proxy
Purchasers
Amount not stated
As of the Record Date

Holdings of the Purchasers in the Company: common stock and Series C Preferred Stock convertible into common stock, acquired in the Private Placement.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support